We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Confiscated and surrendered drugs will be tested to identify toxic substances in circulation and help prevent drug-related overdoses.
Apply for a High Potential Individual (HPI) visa if you've been awarded a qualification by an eligible university in the last 5 years - eligibility, fees, documents, switch, bring your partner and children
Incident planning for potent synthetic opioids arriving into the illicit drug market.
Guide to licensing procedure and other restrictions for export of controlled dual-use items, software and technology, goods for torture and radioactive sources.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Ministry of Defence’s assessment of strategic technologies that will drive modernisation and deliver future battle-winning capabilities for our UK Armed Forces.
The review will examine the harm that drugs cause and look at prevention, treatment and recovery.
How to use a factorial randomised controlled trial to evaluate your digital health product.
General Sir Patrick Sanders, Chief of the General Staff, delivered his keynote speech at Defence and Security Equipment International (DSEI) 2023.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).